Finance

Lists
VFY:ASX
Vitrafy Life Sciences Ltd
A$2,75
+1,48%
(+0,040) 1D
20 Okt., 16:10:25 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for VFY...
Open
A$2,82
High
A$2,82
Low
A$2,65
Mkt. cap
171,43 m
Avg. vol.
53,28 k
Volume
49,86 k
52-wk high
A$4,66
52-wk low
A$1,20
EPS
-A$0,21
Shares outstanding
76,24 m
No. of employees
22
Open
A$2,82
High
A$2,82
Low
A$2,65
Mkt. cap
171,43 m
Avg. vol.
53,28 k
Volume
49,86 k
52-wk high
A$4,66
52-wk low
A$1,20
EPS
-A$0,21
Shares outstanding
76,24 m
No. of employees
22
News stories
From web sources and news partners
About Vitrafy Life Sciences Ltd
CEOKate Munnings
Employees22
Founded2017
Headquarters-
SectorHealth care
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
991,52 k
991,52 k
-887,02 k
-887,02 k
Cost of goods sold
2,55 m
2,55 m
1,78 m
1,78 m
Cost of revenue
2,55 m
2,55 m
1,78 m
1,78 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,19 m
2,19 m
3,69 m
3,69 m
Operating expense
2,19 m
2,19 m
1,97 m
1,97 m
Total operating expenses
4,75 m
4,75 m
3,75 m
3,75 m
Operating income
-3,75 m
-3,75 m
-4,63 m
-4,63 m
Other non operating income
-
-
-1,32 k
-1,32 k
EBT including unusual items
-3,56 m
-3,56 m
-4,52 m
-4,52 m
EBT excluding unusual items
-3,56 m
-3,56 m
-4,44 m
-4,44 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-1,72 m
-1,72 m
Net income
-3,56 m
-3,56 m
-4,52 m
-4,52 m
Net profit margin
-359,27%
-359,27%
509,94%
509,94%
Earnings per share
-
-
-
-
Interest and investment income
196,22 k
196,22 k
202,55 k
202,55 k
Interest expense
-5,02 k
-5,02 k
-4,42 k
-4,42 k
Net interest expenses
191,20 k
191,20 k
198,12 k
198,12 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,74 m
-3,74 m
-4,62 m
-4,62 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme